0
0.5
1
1.5
2+
Mortality
-196%
Improvement
Relative Risk
ICU admission
76%
Recovery
-42%
Viral clearance
43%
Favipiravir AlQahtani et al. LATE TREATMENT RCT
Is late treatment with favipiravir beneficial for COVID-19?
RCT 106 patients in Bahrain (August 2020 - March 2021)
Lower ICU admission (p=0.2) and worse recovery (p=0.51), not sig.
c19early.org
AlQahtani et al., Scientific Reports, Mar 2022
Favors favipiravir
Favors control